A
Agile Therapeutics Inc
F:0AL
Agile Therapeutics Inc
F:0AL
Price:
1.11
EUR
-1.77%
Market Closed
Market Cap:
€9.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Agile Therapeutics Inc
F:0AL
|
US |
|
P
|
Patrizia SE
SWB:PAT
|
DE |
|
B
|
Banca Intermobiliare di Investimenti e Gestioni SpA
MIL:BIM
|
IT |
|
Orient Paper and Industries Ltd
NSE:ORIENTPPR
|
IN |
|
M
|
Merus Power Oyj
OMXH:MERUS
|
FI |
|
Iridium Communications Inc
NASDAQ:IRDM
|
US |
|
Hudson Pacific Properties Inc
NYSE:HPP
|
US |
|
Mercadolibre Inc
NASDAQ:MELI
|
AR |
|
AbL Diagnostics SA
PAR:ABLD
|
FR |
|
R
|
Relais Group Oyj
OMXH:RELAIS
|
FI |
|
W
|
Westwater Resources Inc
F:UCCP
|
US |
|
Seadrill Ltd
OSE:SDRL
|
BM |
|
Remitly Global Inc
NASDAQ:RELY
|
US |
|
Ennis Inc
NYSE:EBF
|
US |
|
Origin Materials Inc
NASDAQ:ORGN
|
US |
|
Fuchun Technology Co Ltd
SZSE:300299
|
CN |
|
Chunghwa Telecom Co Ltd
NYSE:CHT
|
TW |
|
C
|
Chi Kan Holdings Ltd
HKEX:9913
|
HK |
|
B
|
Bceg Environmental Remediation Co Ltd
SZSE:300958
|
CN |
|
Inspiration Healthcare Group PLC
LSE:IHC
|
UK |
Balance Sheet
Balance Sheet Decomposition
Agile Therapeutics Inc
Agile Therapeutics Inc
Balance Sheet Decomposition is not available for
Agile Therapeutics Inc
Agile Therapeutics Inc
Balance Sheet
Agile Therapeutics Inc
Agile Therapeutics Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
40
|
34
|
49
|
36
|
8
|
34
|
14
|
19
|
5
|
3
|
|
| Cash Equivalents |
40
|
34
|
49
|
36
|
8
|
34
|
14
|
19
|
5
|
3
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
40
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
3
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
|
| Other Current Assets |
1
|
4
|
3
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
|
| Total Current Assets |
41
|
38
|
52
|
37
|
8
|
35
|
57
|
24
|
11
|
10
|
|
| PP&E Net |
12
|
12
|
12
|
14
|
14
|
14
|
14
|
13
|
1
|
0
|
|
| PP&E Gross |
12
|
12
|
0
|
14
|
14
|
14
|
14
|
13
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Other Long-Term Assets |
2
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
0
|
|
| Total Assets |
55
N/A
|
50
-8%
|
64
+27%
|
51
-21%
|
22
-56%
|
50
+121%
|
73
+47%
|
39
-46%
|
14
-64%
|
10
-28%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3
|
2
|
2
|
3
|
1
|
2
|
4
|
9
|
8
|
10
|
|
| Accrued Liabilities |
1
|
3
|
4
|
1
|
1
|
2
|
3
|
4
|
4
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
5
|
2
|
5
|
11
|
0
|
0
|
0
|
17
|
1
|
2
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
9
|
8
|
11
|
14
|
2
|
4
|
7
|
29
|
13
|
21
|
|
| Long-Term Debt |
10
|
13
|
11
|
0
|
0
|
0
|
16
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
6
|
|
| Total Liabilities |
19
N/A
|
21
+10%
|
22
+4%
|
14
-34%
|
2
-84%
|
4
+71%
|
24
+524%
|
30
+27%
|
20
-34%
|
27
+34%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
134
|
165
|
193
|
222
|
242
|
260
|
312
|
387
|
409
|
423
|
|
| Additional Paid In Capital |
170
|
194
|
236
|
258
|
262
|
306
|
362
|
396
|
403
|
407
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
36
N/A
|
30
-17%
|
42
+42%
|
36
-14%
|
20
-44%
|
46
+127%
|
49
+8%
|
9
-81%
|
6
N/A
|
16
-194%
|
|
| Total Liabilities & Equity |
55
N/A
|
50
-8%
|
64
+27%
|
51
-21%
|
22
-56%
|
50
+121%
|
73
+47%
|
39
-46%
|
14
-64%
|
10
-28%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
